NVDA: BULLSEYE! 🎯 What to expect from here?
• Yes, we nailed the 61.8% Fibonacci’s Retracement in the weekly chart. We set this target on my previous public analysis on NVDA (the link is below this post, as usual);
• Now, it seems NVDA is trying to react above the retracement. In addition, it just filled a gap around $142 (daily chart), which did work as a support level on Dec 29 – 30;
• So far, there’s a bottom sign, but not a reversal structure yet. The trend would technically reverse if NVDA breaks the 21 ema in the daily chart – so far, the 21 ema is above the price, pointing downwards;
• On the bright side, there’s a Hammer candlestick pattern in the weekly chart. As Bulkowski’s studies reveal, Hammers have 60% chances of reversing the trend, therefore, this might be a catalyst for NVDA;
• On the other hand, what could trigger a bearish continuation for NVDA? If it loses the 61.8% again. In this case, the next technical support level is the $129 (daily chart);
• I’ll keep you guys updated on this.
Remember to follow me to keep in touch with my daily analyses!
• Now, it seems NVDA is trying to react above the retracement. In addition, it just filled a gap around $142 (daily chart), which did work as a support level on Dec 29 – 30;
• So far, there’s a bottom sign, but not a reversal structure yet. The trend would technically reverse if NVDA breaks the 21 ema in the daily chart – so far, the 21 ema is above the price, pointing downwards;
• On the bright side, there’s a Hammer candlestick pattern in the weekly chart. As Bulkowski’s studies reveal, Hammers have 60% chances of reversing the trend, therefore, this might be a catalyst for NVDA;
• On the other hand, what could trigger a bearish continuation for NVDA? If it loses the 61.8% again. In this case, the next technical support level is the $129 (daily chart);
• I’ll keep you guys updated on this.
Remember to follow me to keep in touch with my daily analyses!
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.